Key facts
- This page summarizes Cecile Munnik's Form 4 filing for Progressive Care Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Nov 2022, 15:41.
Cecile Munnik - 14 Nov 2022 Form 4 Insider Report for Progressive Care Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 14 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Nov 2022, 15:41:35 UTC
- Prior SEC filing
- 06 Jan 2022
- Next SEC filing
- 09 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cecile Munnik
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Cecile Munnik filed Form 4 for Progressive Care Inc. on 16 Nov 2022.
Change
- Previous filing in this sequence was filed on 06 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RXMD
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +5,000,000
- Change %
- Price
- Shares after
- 5,000,000
- Date
- 14 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000,000
- Exercise price
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The options vested immediately but have not been exercised pursuant to the Stock Option Award Agreement.
Footnote F2
The price per share of the Shares subject to the Option shall not be less than 100% of the Fair Market Value of a Share on the Date of Grant. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and the Reporting Person is a Ten Percent Holder as of the Date of Grant, the exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Date of Grant.
Footnote F3
The Option shall commence on Grant Date and terminate on the date of first to occur of: (1) If Option is designated as an Incentive Stock Option and Reporting Person, at time Option was granted, was a 10% Holder, the expiration of (5) years from Date of Grant; (2) 10th anniversary of Date of Grant; (3) (1) year following Reporting Person's termination of Continuous Service Status with Issuer and its Affiliates as a result of termination of service of Reporting Person by Issuer or any of its Affiliates on account of death or Disability; (4) (30) days following Reporting Person's termination of service of a Participant with Issuer and its Affiliates as a result of termination of service of a Participant by Reporting Person other than for Cause; and (5) Close of business on last business day immediately prior to date of Reporting Person's termination of service by Issuer for Cause or for any reason other than as set forth above.
Footnote F4
This number does not represent the 1,000,000 shares of the Company's common stock, or non-derivative securities, held by Cecile Munnik as of the date of this Form 4.